Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for vascular function in overweight youth with type 1 diabetes
ACTRN12611000148976Phase 4Recruiting
- Sponsor
- Alexia Pena
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Alexia Pena. Primary endpoint: Vascular function at 12 months. Started Feb 2011; status: recruiting.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12611000148976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000148976.